Beatriz San Martin

Beatriz is a Partner in the IP & Technology Dispute Resolution Group at Field Fisher Waterhouse LLP.  She has a degree and PhD from the University of Cambridge specialising in genetics, cellular and molecular biology. Beatriz has a broad practice area advising clients in all aspects of intellectual property, with a particular focus on patents,…

Phil Bilney

Phil Bilney is a solicitor in the IP & Technology Dispute Resolution Group at Field Fisher Waterhouse LLP.  Phil advises on a wide range of IP disputes, with a particular emphasis on patent related disputes.  He has acted for a range of clients, and has a keen interest in the Life Sciences sector having studied…

Competition versus Patents – Anatomy of an underlying policy tension

By Bertold Bär-Bouyssière[1] 2013 has seen significant tensions between antitrust enforcement and patents. The various “pay for delay” cases are the most visible development, but there are many others. increasingly, competition authorities challenge the use of patents or virtually ignore them when applying competition law. What is the ideology behind these occurrences? The short article…

LIFE SCIENCES – WEEKLY INDUSTRY NEWS

Belarus Ambulance Doctors: Underpaid And Overworked, by Vadzim Smok, Posted on BelarusDigest Leading up to New Year’s Eve and throughout the first week of 2014, employees of the Minsk municipal ambulance service launched a protest. They are demanding a raise in salaries and improved labour conditions. The healthcare sector in Belarus remains financed by the state and has…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Key Energy Services, Inc. – KEG

NEW YORK, Jan. 7, 2014 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Key Energy Services, Inc. (“Key Energy” or the “Company”)(NYSE: KEG). Such investors are advised to contact Robert S. Willoughby at [email protected] or 1-888-476-6529, ext. 237. The investigation concerns whether Key Energy and certain of its officers and/or directors…

Patent Settlements as an endangered species

  Authors       James R.M. Killick   Partner   White & Case   Practice Experience   James Killick heads the Firm’s Global Pharmaceuticals and Healthcare practice. He is a litigator with a broad range of European law experience, advising clients on pharmaceuticals, competition, international trade (customs, export control, dumping) and State aid. He…

Anti-Corruption & Fraud – Industry News

Spain targets political parties with new anti-corruption law, Posted on Reuters (Reuters) – Spain’s government proposed a law on Friday to control more tightly the financial activities of political parties, after corruption scandals in recent years involving both left and right. The law will ban legal and corporate entities from making donations to parties, and banks…

International Trade Compliance – Industry News

 US could block MoD sell-off plans over security fears, By Toby Helm and Peter Beaumont, Posted on The Guardian  Secrets of shared military technology could be jeopardised by privatisation of equipment repair and maintenance arm. The US could block plans by the British government to privatise theMinistry of Defence‘s equipment repair and maintenance arm because of fears over the…

Pharma and Biotech Patent Litigation

The Chinese People’s Court shifts the burden of proof to the defendant in a known-compound preparing process patent infringement case By Dr. Stephen ZOU* Due to lack of discovery procedure, in China, it is very difficult for the patentee to enforce a process patent, especially a process patent for a known product. In Ashland Licensing and…

Pharma and Biotech Patent Litigation

The Chinese Supreme People’s Court expressly opines how to construe a close-ended claim, By Dr. Stephen ZOU* In the [2012] Civil Retrial No. 10, the Chinese Supreme People’s Court (hereinafter “SPC”) delivers its opinion regarding how to construe a close-ended claim. The patent at issue claims a freeze-dried powder injection, consisting of ATP and magnesium chloride…

The current scenario of mailbox patents in Brazil

  Overview An Opinion drafted by the Brazilian Patent and Trademark Office (BPTO) legal department regarding the patent term for pharmaceutical products or chemical products for agriculture filed between January 1st, 1995 and May 14th, 1997, the so called “mailbox” patents, was published in the official patent gazette on September 10th, 2013. On September 11th,…